Innovative therapeutics with a de-risk approach
PurMinds operates out of a NeuroLab and Health Canada Controlled Substance approved production facility in Ontario, Canada.
PurMinds owns and operates a portfolio of technical assets and special licenses that give the Company a competitive edge. We de-risk our enterprise portfolio by innovating best-in-class therapeutics with proven mechanisms of action. In addition, PurMinds is developing our own proprietary botanical psilocybin formulation for global supply, serving as a revenue-generating asset.
Our People
With strong management, scientific and business backgrounds, our team is committed to developing best-in-class disease-modifying therapeutics for neurological conditions. Collectively, we work to develop novel medicines that address underlying pathologies associated with a variety of CNS disorders. Ultimately, our goal is to revolutionize patient outcomes and enhance their quality of life.
Our Team
Founder,
President & Chief Executive Officer
A serial entrepreneur and strategic visionary with 15+ years of corporate banking experience and 8+ years of strategic management and business development work in investment, biotech and branding marketing field.
Chief Scientific Officer
Dr. Kozikowski is a Global leader in medicinal chemistry designing Novel Chemical Entities (NCEs) for oncology and neuroscience. He worked as a Professor for over 40 years at a number of prestigious universities in the field of medicinal chemistry, and is known for his research on 5-HT receptors, HDAC and GSK-3 inhibitors, and has over 100 patents and over 550 publications.
Chief Innovation Officer
A recognized leader in neuroscience and neuropharmacology; specializing in psychedelic clinical development, neurodegeneration, and nutritional neurobiology; with 15 years of expertise in translational medicine spanning from molecules to mind
Chief Financial Officer &
Chief Operating Officer
Senior Financial Leader with 30+ years experience in FP&A, Business Valuation, general accounting, risk management, and in driving financial and operational excellence.
Vice President, NeuroLabs
Over 25 years of experience in laboratory operation and management, scientific research team leadership in chemistry, multi-omics for biomarker based precision medicine.
Vice President, Technology
Strong science background with extensive experience in research and development for laboratory and production technology. Ms. Kim plays a key role in the advancement of PurMinds botanical production process, and is desired to support the development of new therapies for devastating neurological diseases.
Senior Director,
Scientific Programs
Dr. Francis is a neuroscientist specializing in behavioural neuropharmacology, with 6+ years of experience investigating pathological mechanisms and therapeutic strategies for a variety of psychiatric and neurological conditions.
Clinical Investigator
Co-Principal Investigator of Psychedelic clinical trials and adjunct teaching faculty in Johns Hopkins University.
Director, Quality and
Regulatory Affairs
With extensive experience and a long track-record in quality assurance and regulatory affairs, Mr. Wallace is helping Purminds navigate the regulatory framework of Health Canada, the US FDA and the European Medicines Agency (EMA).
Scientific Advisory Board
An accomplished biotech & pharma entrepreneur. Extensive experience in novel drug candidate/technology development, transfer, and commercialization in the biotechnology and life sciences space.
Ph.D.
Professor of Neurobiology
Director,
Brain Research Center
Southern University of Science and Technology (SUSTech)
Adjunct Professor
University of Ottawa Health Services
Honorary Professor
Queensland Brain Institute
The University of Queensland (UQ)
Executive Director,
SUSTech-UQ Joint Center for Neuroscience & Neural Engineering
Ph.D.
Partner &
Patent Agent,
registered to act before the Canadian and United States Patent Offices, with specialties in biochemistry, organic chemistry, biotechnology, pharmaceutical inventions, food science, medical devices, simple mechanics and business methods
BENOÎT & CÔTÉ,